Global Longlife Hospital & Research Ltd. operates as a multi-specialty tertiary care hospital. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-05-04. The firm's medical services include oncology, ophthalmology, allergy & immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes & endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery and ear, nose and throat (ENT). Its radiology services include mammography, CT scan, X-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
21 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.